Company News

It has been defined that tumor biomarkers—substances generated by tumors or the body's reactions to tumors during their development and progression—have important and positive applications in cancer screening, early diagnosis, prognosis prediction, recurrence detection, and therapeutic efficacy monitoring. Exploration and the discovery of new, sensitive, specific, and accurate tumor biomarkers have advanced steadily over the past few decades, greatly advancing personalized medicine and improving the prognosis of cancer patients. This is especially true of advancements in molecular biology technologies created for tumor biomarker detection. 

Innovative Solutions for Targeted Oncology Treatment 

Molecular targeted therapy for anticancer treatment 

A key component of precision medicine for the treatment of cancer has been molecular targeted therapy, which uses therapeutic monoclonal antibodies or small molecule medicines that function as signal transduction inhibitors. These methods are currently employed as first-line treatments in clinical settings for a variety of human cancer types. Targeted therapeutic medicines provide more effective anticancer effects and fewer side effects than traditional chemotherapy. A significant disadvantage of molecular targeted therapy is the development of drug resistance, and various approaches have been tried to increase therapeutic efficacy by overcoming this resistance.  

Bridging the advanced user-friendly technology 

The Easy PGX qPCR solution of Diatech Pharmacogenetics is a cutting-edge diagnostic tool that utilizes real-time quantitative polymerase chain reaction (qPCR) technology to detect genetic mutations associated with various cancers such as Lung cancer, Colorectal cancer, Thyroid cancer, Breast cancer, and so on. By analyzing DNA samples from patients, this test can identify specific genetic mutations that may influence cancer development, progression, and response to treatment. The high sensitivity and accuracy of qPCR make it an invaluable tool for early cancer detection and personalized treatment planning.  

Diatech Pharmacogenetics oncology PCR tests are CE-IVD certified, which are successfully implemented in many countries worldwide. Diatech Easy PGX qPCR could be well served in Vietnamese Oncology treatment centers for several reasons. Firstly, the pre-load dried, ready-to-use reagent technology of Diatech Pharmacogenetics' Real-time PCR solution helps minimize manual operations for technicians, optimizing the operation process of the laboratories. Secondly, by identifying genetic mutations early, healthcare providers can tailor treatment plans to individual patients, increasing the chances of successful outcomes. Additionally, lyophilized reagent technology also helps ensure a long shelf-life, easy to store at room temperature, minimizing damage to reagents due to improper transportation and/ or storage. 

The Diatech Easy PGX qPCR test is part of the Getz Healthcare Vietnam product portfolio, ensuring that our advanced diagnostic solutions are helpful for Vietnam oncology treatment development. For more information on this innovative tool and how it can benefit your healthcare practice, please contact us.  

Sources:  

• https://www.nature.com/articles/s41392-024-01823-2 
• https://www.nature.com/articles/s12276-022-00864-3 
• https://pmc.ncbi.nlm.nih.gov/articles/PMC9275775/  
• https://www.diatechpharmacogenetics.com/en/easy-pgx-line/